Peer-influenced content. Sources you trust. No registration required. This is HCN.

MDLinxThe Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks

A fact-filled video program all about ALZ-801 (valiltramiprosate), an oral medication with a novel mode of action that aims to slow or stop Alzheimer’s disease altogether.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form